Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1341-1350 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|May 24, 2016
DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loopsBas van der Woning, Gitte De Boeck, Christophe Blanchetot, et al.
Mabs|June 5, 2016
Advanced assessment of the physicochemical characteristics of Remicade® and Inflectra® by sensitive LC/MS techniquesJing Fang, Catalin Doneanu, William R Alley, et al.
Mabs|July 25, 2017
Evolving patterns in a collaboration network of global R&D on monoclonal antibodiesXiangjun Kong, Jian-Bo Wan, Hao Hu, et al.
Mabs|August 9, 2017
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRnDanlin Yang, Craig Giragossian, Steven Castellano, et al.
Mabs|August 9, 2017
Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™Karthik Pisupati, Alexander Benet, Yuwei Tian, et al.
Mabs|August 31, 2017
Forced degradation of recombinant monoclonal antibodies: A practical guideChristine Nowak, Jason K Cheung, Shara M Dellatore, et al.
Mabs|July 27, 2017
Chaperone proteins as single component reagents to assess antibody nonspecificityRyan L Kelly, James C Geoghegan, Jared Feldman, et al.
Mabs|June 17, 2016
Acid-induced aggregation propensity of nivolumab is dependent on the FcBoning Liu, Huaizu Guo, Jin Xu, et al.
Mabs|September 7, 2017
Capacity limits of asialoglycoprotein receptor-mediated liver targetingCharlotte Bon, Thomas Hofer, Alain Bousquet-Mélou, et al.
Mabs|April 26, 2016
Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeysAmita Datta-Mannan, Johnny E Croy, Linda Schirtzinger, et al.
Pageof 178

Showing results (1341-1350 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|May 24, 2016
DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loopsBas van der Woning, Gitte De Boeck, Christophe Blanchetot, et al.
Mabs|June 5, 2016
Advanced assessment of the physicochemical characteristics of Remicade® and Inflectra® by sensitive LC/MS techniquesJing Fang, Catalin Doneanu, William R Alley, et al.
Mabs|July 25, 2017
Evolving patterns in a collaboration network of global R&D on monoclonal antibodiesXiangjun Kong, Jian-Bo Wan, Hao Hu, et al.
Mabs|August 9, 2017
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRnDanlin Yang, Craig Giragossian, Steven Castellano, et al.
Mabs|August 9, 2017
Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™Karthik Pisupati, Alexander Benet, Yuwei Tian, et al.
Mabs|August 31, 2017
Forced degradation of recombinant monoclonal antibodies: A practical guideChristine Nowak, Jason K Cheung, Shara M Dellatore, et al.
Mabs|July 27, 2017
Chaperone proteins as single component reagents to assess antibody nonspecificityRyan L Kelly, James C Geoghegan, Jared Feldman, et al.
Mabs|June 17, 2016
Acid-induced aggregation propensity of nivolumab is dependent on the FcBoning Liu, Huaizu Guo, Jin Xu, et al.
Mabs|September 7, 2017
Capacity limits of asialoglycoprotein receptor-mediated liver targetingCharlotte Bon, Thomas Hofer, Alain Bousquet-Mélou, et al.
Mabs|April 26, 2016
Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeysAmita Datta-Mannan, Johnny E Croy, Linda Schirtzinger, et al.
Pageof 178